FranΓ§aisπ See the interactive version (live chart) β
For BrightSpring Health Services, Inc., we replayed every analyst price target of the past 12 months and measured the real outcome: 100% were profitable, average return +101% (24 calls). At 3 months: +21% average return (86% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
Not enough scored calls for a reliable ranking.
The analyst consensus on BrightSpring Health Services, Inc. (BTSG) is "Buy" (45 bullish, 0 bearish calls over 12 months). This is not advice: historically, 100% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $80.00 (+31% vs $60.90), ranging from $60.00 to $90.00 (13 analysts).
Over 1 year, 100% of analyst targets on BrightSpring Health Services, Inc. were profitable, for an average return of +101% (across 24 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $80.00 within 12 months, i.e. +31% vs the current price. The most bullish targets $90.00, the most cautious $60.00.
Note: analyst targets are 12-month (median $80.00, +31%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (100%), and the stock's past trajectory.
Detailed valuation data for BrightSpring Health Services, Inc. is available in the interactive analysis.
π See the full interactive analysis of BrightSpring Health Services, Inc. β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.